COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?


Journal

Basic research in cardiology
ISSN: 1435-1803
Titre abrégé: Basic Res Cardiol
Pays: Germany
ID NLM: 0360342

Informations de publication

Date de publication:
09 04 2020
Historique:
received: 21 03 2020
accepted: 30 03 2020
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 16 4 2020
Statut: epublish

Résumé

From January 2020, coronavirus disease (COVID-19) originated in China has spread around the world. The disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest, and acute heart failure in COVID-19 patients suggests the existence of a relationship between SARS-CoV-2 infection and cardiac disease. The Notch signalling is a major regulator of cardiovascular function and it is also implicated in several biological processes mediating viral infections. In this report we discuss the possibility to target Notch signalling to prevent SARS-CoV-2 infection and interfere with the progression of COVID-19- associated heart and lungs disease.

Identifiants

pubmed: 32274570
doi: 10.1007/s00395-020-0791-5
pii: 10.1007/s00395-020-0791-5
pmc: PMC7144545
doi:

Substances chimiques

Interleukin-6 0
Receptors, Notch 0
Peptidyl-Dipeptidase A EC 3.4.15.1
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Furin EC 3.4.21.75
ADAM17 Protein EC 3.4.24.86
ADAM17 protein, human EC 3.4.24.86

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Références

Int Arch Allergy Immunol. 2019;179(1):43-52
pubmed: 30943513
Front Immunol. 2019 May 22;10:1130
pubmed: 31191522
PLoS Pathog. 2011 Nov;7(11):e1002341
pubmed: 22072963
Sci Adv. 2017 Apr 05;3(4):e1601556
pubmed: 28435870
Cell Mol Immunol. 2012 Mar;9(2):155-62
pubmed: 21983868
Viral Immunol. 2008 Jun;21(2):115-22
pubmed: 18419253
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Eur Heart J. 2020 Apr 1;41(13):1320-1322
pubmed: 32236465
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Nat Rev Immunol. 2007 Jan;7(1):64-75
pubmed: 17170755
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Eur Heart J. 2014 Aug 21;35(32):2140-5
pubmed: 24970336
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Med Virol. 2020 Apr;92(4):455-459
pubmed: 31994738
Ann Rheum Dis. 2015 Jan;74(1):267-74
pubmed: 24255545
Eur J Prev Cardiol. 2020 May;27(8):793-796
pubmed: 32241182
Eur Heart J. 2013 Aug;34(32):2504-9
pubmed: 22645188
J Am Heart Assoc. 2014 Oct 27;3(6):e001064
pubmed: 25349182
J Biol Chem. 2005 Aug 26;280(34):30113-9
pubmed: 15983030
Neoplasia. 2013 Feb;15(2):218-30
pubmed: 23441135
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Steroid Biochem Mol Biol. 2019 May;189:87-100
pubmed: 30817989
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Cell Rep. 2015 Jan 13;10(2):239-52
pubmed: 25558064
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Virol J. 2019 May 27;16(1):69
pubmed: 31133031
Lancet Infect Dis. 2010 Feb;10(2):83-92
pubmed: 20113977
Arterioscler Thromb Vasc Biol. 2011 May;31(5):1059-65
pubmed: 21330605
Cell Mol Immunol. 2015 Nov;12(6):768-76
pubmed: 25363527
J Biol Chem. 2011 Aug 12;286(32):28312-21
pubmed: 21685392
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Hypertens Res. 2006 Nov;29(11):865-74
pubmed: 17345786
Mol Cell Biol. 2015 Nov;35(21):3622-32
pubmed: 26283728
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
Am J Hypertens. 2005 May;18(5 Pt 1):720-30
pubmed: 15882557
J Biol Chem. 2007 Jul 20;282(29):20847-53
pubmed: 17537721
Expert Opin Ther Targets. 2019 Aug;23(8):695-710
pubmed: 31304807
Transplantation. 2016 Dec;100(12):2593-2600
pubmed: 27607530
J Mol Cell Cardiol. 2014 Jan;66:167-76
pubmed: 24332999
J Thorac Oncol. 2020 May;15(5):675-678
pubmed: 32151778
Basic Res Cardiol. 2013 Sep;108(5):373
pubmed: 23989801
J Alzheimers Dis. 2016 Jul 6;53(4):1395-404
pubmed: 27392862
Front Cell Infect Microbiol. 2018 Jul 10;8:241
pubmed: 30042932
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Basic Res Cardiol. 2015 May;110(3):29
pubmed: 25893875
Clin Cancer Res. 2010 Jul 1;16(13):3378-89
pubmed: 20570921

Auteurs

Paola Rizzo (P)

Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy. rzzpla@unife.it.
Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy. rzzpla@unife.it.

Francesco Vieceli Dalla Sega (F)

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Francesca Fortini (F)

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Luisa Marracino (L)

Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.

Claudio Rapezzi (C)

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Cardiovascular Center, University Hospital of Cona, Ferrara, Italy.

Roberto Ferrari (R)

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Cardiovascular Center, University Hospital of Cona, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH